0
0
32 words
0
Comments
Citi upgrades Hims & Hers to neutral after Novo Nordisk GLP-1 deal, raising price target to $24. Read more here.
You are the first to view
https://seekingalpha.com/news/4562501-hims-hers-health-boosted-at-citi-on-novo-nordisk-partnership
Create an account or login to join the discussion